Skip to main content
GutCited

Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection.

Atsushi Ushiyama, Kazuo Tanaka, Yuji Aiba, Tadahiko Shiba, Atsushi Takagi et al.
Other Journal of gastroenterology and hepatology 2003 77 citations

Study Design

Study Type
Controlled Clinical Trial
Population
CAM-resistant H. pylori-infected patients
Duration
8 weeks
Intervention
Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. L. gasseri OLL2716 yogurt
Comparator
CAM-resistant H. pylori patients
Primary Outcome
H. pylori suppression
Effect Direction
Positive
Risk of Bias
Moderate

Abstract

BACKGROUNDS AND AIM: Clarithromycin (CAM)-resistant Helicobacter pylori sometimes offers serious problems with eradication by antibiotics. The aim of this study was to determine whether a probiotic can be an alternative therapy in CAM-resistant Hp infection. METHODS: The effects of Lactobacillus gasseri (strain OLL2716) on the growth of CAM-susceptible and CAM-resistant H. pylori and interleukin (IL)-8 production provoked by these strains were examined by in vitro experiments. Moreover, mice were infected with these CAM-susceptible or CAM-resistant H. pylori, and were treated with CAM or L. gasseri. RESULTS: In vitro experiments demonstrated that L. gasseri inhibited the growth of H. pylori and suppressed H. pylori-associated IL-8 production. Such effects were noted in CAM-resistant and CAM-susceptible H. pylori. Similarly, in an in vivo model of H. pylori infection, H. pylori colonization was significantly decreased by L. gasseri. CONCLUSION: Therefore, L. gasseri was found to act as a probiotic in CAM-resistant H. pylori infection.

TL;DR

The aim of this study was to determine whether a probiotic can be an alternative therapy in CAM‐resistant Hp infection.

Used In Evidence Reviews

Similar Papers

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.